While we have Amazing Search we also deliver a full complement of artifacts from EDGAR to our clients - here is one example

At Sept. 18, 2026, 4:33 p.m., Neuphoria Therapeutics Inc. (CIK: 1191070) reported their Executive Compensation in a recent DEF 14A. Here is the original data:


Name and Principal Position
Fiscal
Year
Salary
Bonus
Stock
Awards
Option
Awards(1)
Non-Equity Incentive
Plan Compensation
Nonqualified Deferred
Compensation
Earnings
All Other
Compensation
Total
Spyros Papapetropoulos, MD.
President and Chief Executive Officer
2025
$550,000
$226,875
$—
$95,850
$—
$—
$50,808
$923,533
Spyros Papapetropoulos, MD.(3)
President and Chief Executive Officer
2026
$284,625
$
$—
$272,325
$—
$—
$1,117,740
$1,674,690
Tim Cunningham(2) Chief Financial
Officer
2025
$
$
$—
$
$—
$—
$254,363
$254,363
Tim Cunningham Chief Financial
Officer
2026
$
$
$—
$
$—
$—
$325,894
$325,894


While the presentation is nice, it is not quite ready for analysis. Within minutes after the filing was made our platform captured the filing, parsed the data and organized it so that it is now ready to be pushed into a database or used in analytical models. Some of the key enhancements we made included adding the personal CIK of the named officers as well as their GENDER and the name they use in their SEC filings.


PERSON-NAMEPERSON-TITLEYEARSALARYBONUSSTOCKOPTIONNONEQUITYNQDEFCOMPOTHERTOTALSEC-NAMEPERSON-CIKGENDER
SPYROS PAPAPETROPOULOS MD.PRESIDENT AND CHIEF EXECUTIVE OFFICER20255500002268759585050808923533PAPAPETROPOULOS SPYROS1832694M
SPYROS PAPAPETROPOULOS MD.PRESIDENT AND CHIEF EXECUTIVE OFFICER202628462527232511177401674690PAPAPETROPOULOS SPYROS1832694M
TIM CUNNINGHAMCHIEF FINANCIAL OFFICER2025254363254363CUNNINGHAM TIMOTHY M.1757426M
TIM CUNNINGHAMCHIEF FINANCIAL OFFICER2026325894325894CUNNINGHAM TIMOTHY M.1757426M